WHITEHAWK THERAPEUTICS, INC. (WHWK) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | -79.83M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-79.83M | (m) |
| 2026-03-31 | (m) | $-115.81M | (m) |
| 2025-12-31 | (m) | $-20.60M | (m) |
| 2025-09-30 | (m) | $-15.62M | (m) |
| 2025-06-30 | (m) | $-10.42M | (m) |
| 2025-03-31 | (m) | $27.61M | (m) |
| 2024-12-31 | (m) | $-63.69M | (m) |
| 2024-09-30 | (m) | $-61.69M | (m) |
| 2024-06-30 | (m) | $-65.44M | (m) |
| 2024-03-31 | (m) | $-68.83M | (m) |
| 2023-12-31 | (m) | $-65.77M | (m) |
| 2023-09-30 | (m) | $-63.41M | (m) |
| 2023-06-30 | (m) | $-61.58M | (m) |
| 2023-03-31 | (m) | $-61.88M | (m) |
| 2022-12-31 | $0.00 | $-60.51M | 0.00% |
| 2022-09-30 | $0.00 | $-62.59M | 0.00% |
| 2022-06-30 | (m) | $-135.20M | (m) |
| 2022-03-31 | (m) | $-118.47M | (m) |
| 2021-12-31 | $4.41M | $-110.09M | -4.01% |
| 2021-09-30 | (m) | $-86.92M | (m) |
| 2021-06-30 | (m) | $-18.52M | (m) |
| 2021-03-31 | (m) | $-4.84M | (m) |
| 2020-12-31 | (m) | $-4.32M | (m) |
| 2020-09-30 | (m) | $-4.04M | (m) |
| 2020-06-30 | (m) | $-3.74M | (m) |
| 2020-03-31 | (m) | $-18.70M | (m) |
| 2019-12-31 | (m) | $-23.27M | (m) |
| 2019-09-30 | (m) | $-27.34M | (m) |
| 2019-06-30 | (m) | $-11.16M | (m) |
| 2019-03-31 | (m) | $-11.46M | (m) |
| 2018-12-31 | (m) | $-10.40M | (m) |
| 2018-09-30 | (m) | $-8.11M | (m) |
| 2018-06-30 | (m) | $-24.30M | (m) |
| 2018-03-31 | (m) | $-23.83M | (m) |
| 2017-12-31 | (m) | $-21.40M | (m) |
| 2017-09-30 | (m) | $-1.74M | (m) |
| 2017-06-30 | (m) | $-1.98M | (m) |
| 2017-03-31 | (m) | $-840.44K | (m) |
| 2016-12-31 | (m) | $-39.43K | (m) |
| 2016-09-30 | (m) | $-32.61K | (m) |
| 2016-06-30 | (m) | $-32.35K | (m) |
| 2016-03-31 | (m) | $-31.98K | (m) |
| 2015-12-31 | (m) | $-31.44K | (m) |
| 2015-09-30 | (m) | $-31.26K | (m) |
| 2015-06-30 | (m) | $-31.17K | (m) |
| 2015-03-31 | (m) | $-30.85K | (m) |
| 2014-12-31 | (m) | $-30.80K | (m) |
| 2014-09-30 | (m) | $-28.90K | (m) |
| 2014-06-30 | (m) | $-28.61K | (m) |
| 2014-03-31 | (m) | $-28.40K | (m) |
| 2013-12-31 | (m) | $-28.70K | (m) |
| 2013-09-30 | (m) | $-28.61K | (m) |
| 2013-06-30 | (m) | $-28.51K | (m) |
| 2013-03-31 | (m) | $-28.07K | (m) |
| 2012-12-31 | (m) | $-27.36K | (m) |
| 2012-09-30 | (m) | $-26.64K | (m) |
| 2012-06-30 | (m) | $-26.94K | (m) |
| 2012-03-31 | (m) | $-27.39K | (m) |
| 2011-12-31 | (m) | $-27.18K | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-22.39K | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-20.00K | (m) |
| 2008-12-31 | (m) | $-33.62K | (m) |
| 2007-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |